TD Bank Q3 2026 slides: record earnings beat targets across segments

TD reported fiscal Q3 2026 adjusted EPS of CAD 2.77 (+26% YoY) and adjusted net income of CAD 4.7B, beating expectations by 13.1% (EPS) and 11.6% (revenue). Credit quality improved with PCL down QoQ to $917M and guidance cut for fiscal 2026 PCL to the lower end of the prior 40–50 bps range; ROE rose 280 bps to 16.0% and efficiency improved to 55.2%. TD also highlighted ~CAD 195M AI value year-to-date (target ~CAD 200M for FY26) and said it expects to return >CAD 13B via buybacks in FY27 while staying on track toward a 13%+ CET1 ratio. Shares rose modestly (~+0.19%) to $166.19, near the 52-week high, implying most of the strength was already priced in despite the bullish outlook.

Analysis

TD is transitioning from a remediation/cleanup story to a capital-return and operating-leverage story. The key market mechanism is that once a bank gets past peak compliance drag and proves it can compound ROE above its cost of capital, the multiple usually rerates faster than headline EPS growth would suggest; the stock can keep working even if quarterly beats normalize because buybacks amplify per-share growth.

The second-order winner is the broader Canadian-bank complex only if peers can match TD’s mix of loan growth, margin expansion, and capital return without introducing fresh risk. Relative losers are lenders still leaning on balance-sheet repair or with weaker U.S. profitability, because TD is effectively raising the bar on what investors should pay for stable deposit franchises. The branch buildout and AI rollout also matter beyond this print: if TD executes, it pressures regional banks and Canadian incumbents on service quality and cost efficiency, but that benefit will accrue over quarters, not days.

The main risk is that consensus may be over-anchoring on the near-term beat and underestimating execution friction: U.S. AML remediation, regulatory timing for branches, and incremental opex from expansion can delay the 13% CET1 path and push the buyback story rightward. Credit remains the cleanest falsifier—if PCLs re-accelerate or U.S. consumer trends roll over, the market will quickly discount the current optimism. Near term, the move can stall because the stock is already close to highs; the better setup is confirmation on the next earnings cycle or on regulatory approvals, not chasing the print.

Key Decisions for Investors

• Long TD on a 1-3 month pullback; thesis is that the market should pay up for a bank with visible buyback capacity and improving U.S. ROE. Risk/reward is attractive if the stock holds above prior breakout levels and management keeps the CET1 glide path intact.
• Pair trade: long TD / short BMO over the next 1-2 quarters. TD has cleaner capital-return visibility and a clearer U.S. earnings inflection, while BMO still carries more skepticism around U.S. execution and late-cycle credit sensitivity.
• Buy TD 6-12 month call spreads rather than outright stock if chasing momentum from near highs. This expresses the upside from buyback acceleration and branch expansion optionality while capping downside if the market fades the beat.
• Watch for a regulatory-approval headline on U.S. branch expansion; if approvals slip or the 2027 CET1 target looks delayed, cut the bullish case. Falsifier: any guidance revision implying weaker than expected buyback capacity or a re-acceleration in PCLs.
• No direct trade in NVDA from this note; the AI angle is too indirect to justify beta exposure. Treat the AI savings as a 6-18 month bank margin tailwind, not a near-term semiconductor demand signal.